Dr. Hoyme serves as an advisor in genetics and genomic medicine at Sanford Health, the University of South Dakota Sanford School of Medicine and the University of Arizona. He also serves as the Medical Director of the Sanford Children’s Genomic Medicine Consortium, a formal collaborative in pediatric precision medicine among seven major children’s hospitals in the Western U.S. Previously, he functioned as Chair of the Department of Pediatrics of the Sanford School of Medicine, President of Sanford Research and Chief Academic Officer for Sanford Health. He also has held academic appointments and leadership posts at the Stanford University School of Medicine and Lucile Packard Children’s Hospital, Palo Alto, and the University of Vermont College of Medicine, Burlington.
Dr. Hoyme received his BA summa cum laude from Augustana University in Sioux Falls and his MD from the University of Chicago Pritzker School of Medicine. He completed his pediatric residency and clinical genetics and dysmorphology fellowship training at the University of California, San Diego. He is board certified in pediatrics, clinical genetics and clinical cytogenetics. Among his professional affiliations, he is a member of the American Academy of Pediatrics, the American Pediatric Society, the Western Society for Pediatric Research, the Teratology Society, the Research Society on Alcoholism, the American Society of Human Genetics, and the American College of Medical Genetics and Genomics. In 2007-2008, he served as the President of the Western Society for Pediatric Research (WSPR). He is the recipient of myriad local regional and national awards in research, teaching and mentorship, among which are the WSPR’s Joseph W. St. Geme Jr. Education Award (in recognition of outstanding achievement in pediatric education, 2011), the National Organization on Fetal Alcohol Syndrome Excellence Award (2012), and the American Academy of Pediatrics David W. Smith Education and Mentorship Award (2016).
Dr. Hoyme has served numerous leadership roles in regional and national clinical and research organizations in pediatrics and medical genetics. His research focuses on the clinical delineation of genetic and malformation syndromes and fetal alcohol spectrum disorders (FASD). His interest in fetal alcohol spectrum disorders has concentrated on practical, accurate and early diagnosis of affected children. Recently, he served as the first author of revised NIH expert consensus diagnostic guidelines for FASD based on the authors’ evaluation of over 10,000 children for potential FASD world-wide spanning more than 20 years. He has authored over 400 original research articles, book chapters, monographs, electronic publications, research abstracts and a textbook, Signs and Symptoms of Genetic Conditions: A Handbook (Oxford University Press).